| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |